NORML

FEBRUARY 25, 2020

Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. Investigators affiliated with the Saint Anthony Hospital and Medical Campus in Colorado assessed the impact of the off-label use of dronabinol (FDA-approved synthetic oral THC) on opioid consumption patterns in trauma patients with acute pain. Sixty-six patients participated in the study.

Clinical Trials 163

Clinical Trials THC Consumption Therapy 163

NORML

MAY 21, 2019

The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry. In clinical models, CBD administration has been shown to reduce cravings for tobacco. Investigators at The Mount Sinai Health System in New York City assessed the effect of CBD versus placebo in 42 drug-abstinent participants with a history of heroin use.

Clinical Trials 163

Clinical Trials CBD History Data 163

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. A team of Israeli researchers conducted a randomized placebo-controlled clinical trial to assess the safety and efficacy of a novel, metered-dose cannabis inhaler in 27 patients with chronic pain.

Clinical Trials 170

Clinical Trials Chronic Pain Cannabinoids Patients 170

NORML

DECEMBER 6, 2019

The transdermal application of plant-derived CBD reduces fascial pain in patients with temporomandibular disorders (TMD aka TMJ), according to clinical data published in the Journal of Clinical Medicine. Polish investigators conducted a randomized, double-blind placebo-controlled trial assessing the efficacy of twice-daily transdermal CBD administration on 60 patients with TMD over a period of 14 days.

Clinical Trials 103

Clinical Trials Therapy Patients Data 103

Cannabis Law Report

MARCH 30, 2019

The trials, to be tightly controlled in a hospital environment, are exempted from Japan’s Cannabis Control Act, which bans cannabis compounds generally. Ministry of Health, Labor and Welfare officials recently announced the trials during a meeting of the Okinawa-Northern Task Force, a research and development agency. Japanese officials approve Epidiolex for clinical trials.

Clinical Trials 43

Clinical Trials Epilepsy Environment Pharmaceutical 43

Cannabis Life Network

SEPTEMBER 17, 2020

Imagine having a treatment-resistant addition. You’ve tried going to therapy, taking medications, receiving treatment at rehabilitation centres–everything. But none of it worked. Where do you even go from there? What else is there to do?

Clinical Trials 70

Clinical Trials Therapy Treatment Education 70

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. ” “This is a significant milestone for the Company as we transition from a preclinical to a clinical stage organization,” says Eric A.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

Otherside Farms

JANUARY 24, 2019

Federal regulators have approved two clinical studies testing whether a marijuana-based epilepsy drug may help prevent seizures among epileptic children. Our definition of pure is no THC,” Guy said, adding that clinical study would help provide “better understanding and experience in what cannabidiol does in these different children groups, what benefit we can see, and how the results can best be measured.”.

Clinical Trials 43

Clinical Trials Epilepsy Pharmaceutical Cannabinoids 43

The Fresh Toast

MAY 28, 2020

Cannabis Medical Marijuana News RX cannabis inhalers chronic pain clinical trials Neuropathy THCAre Marijuana Inhalers Most Effective Treatment For Chronic Pain? Metered-dose THC inhalers delivered consistent pain relief with minimal adverse effects for neuropathic patients, researchers found. The post Are Marijuana Inhalers Most Effective Treatment For Chronic Pain? appeared first on The Fresh Toast.

Chronic Pain 44

Chronic Pain Clinical Trials Treatment Patients 44

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. ” “This is a significant milestone for the Company as we transition from a preclinical to a clinical stage organization,” says Eric A.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

Project CBD

JUNE 19, 2019

The launch of a clinical trial examining the use of CBD in newborns suffering from hypoxic ischemic encephalopathy (brain damage caused by lack of oxygen) means new hope for the million plus babies born each year with this condition Giving medical cannabis to infants is a difficult taboo to shift, but new research is paving the way.

Clinical Trials 216

Clinical Trials CBD Conditions Cannabis 216

Leafly

SEPTEMBER 15, 2020

In order for a prescription drug to reach the market, it must be extensively studied, first in animal and then in human clinical trials. Safety, efficacy, and risks must be determined. But as anyone who has seen a commercial for a prescription drug knows, there are still side effects.

Clinical Trials 107

Clinical Trials Safety Cannabis 107

Project CBD

OCTOBER 10, 2019

Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials. Pharmaceutical researchers have their sights set on developing a drug that bypasses CB1 while boosting CB2. Referred to as a “selective CB2 agonist ,” such a compound would appear to have potential as a treatment for scleroderma

Cannabinoids 158

Cannabinoids Clinical Trials Pharmaceutical Research and Development 158

Project CBD

MARCH 2, 2020

Recently NIDA supported a clinical trial which used nicotine as a therapy for relatively mild cannabis withdrawal symptoms In its ongoing search for alternatives to recreational cannabis, the National Institute on Drug Abuse ( NIDA ) has been funding research into much more dangerous and addictive drugs — ostensibly to help people ween off cannabis.

Clinical Trials 132

Clinical Trials Therapy Recreational Cannabis 132

Cannabis Law Report

SEPTEMBER 21, 2020

Researchers have announced a phase 1 clinical trial of the popular drug combo. Ravers old and new will be well aware of this practice. “The … Read More. The post “Candy Flipping” — Mixing MDMA and LSD — Is Hitting the Lab first appeared on Cannabis Law Report.

Clinical Trials 56

Clinical Trials Law Cannabis 56

TheAnswerPage

DECEMBER 14, 2019

Are any pre-clinical trials or clinical trials evaluating the therapeutic benefits of CBD currently underway? According to ClinicalTrials.gov, there are more than 40 clinical trials in process to determine if CBD treatment mitigates the symptoms of various disorders/illnesses, including PTSD, alcohol use disorder, anxiety disorders, Sturge-Weber syndrome, pain, autism spectrum disorders, schizophrenia, muscle spasms and some cancers.

Clinical Trials 40

Clinical Trials Treatment CBD 40

The Fresh Toast

JULY 22, 2020

Clinical trial results indicate cannabis could provide an alternative or adjunctive treatment to sickle cell patients. Marijuana Shows Promise In Sickle Cell Disease Treatment.

Clinical Trials 86

Clinical Trials Treatment Patients Marijuana 86

TheAnswerPage

OCTOBER 11, 2020

Clinical trials evaluating the use of human monoclonal antibodies against interleukin 1 and interleukin 6 to treat cytokine storm syndrome in COVID-19 patients are underway or in the planning stage.

Clinical Trials 52

Clinical Trials CBD Patients 52

Cannabis Law Report

JUNE 10, 2020

AS CBD continues to go from strength to strength, both in clinical trials and in the minds of the mainstream, the question of the best … Read More. Pot Luck

Clinical Trials 43

Clinical Trials Oil CBD 43

TheAnswerPage

OCTOBER 3, 2020

A clinical trial evaluating this drug has begun in Italy.) Baricitnib, a drug approved for the treatment of rheumatoid arthritis, may reduce COVID-19 viral entry and mitigate inflammation. (A Does CBD interact with Baricitnib?

Clinical Trials 52

Clinical Trials Treatment CBD 52

NORML

JULY 26, 2019

Federal officials have approved plans for the University of Mississippi to grow 2,000 kilograms (4,409 pounds) of cannabis to provide to investigators for clinical trial research. Clinicians wishing to conduct FDA-approved clinical trials on cannabis have long complained that federally-provided samples are of inferior quality.

Clinical Trials 162

Clinical Trials Strains THC Marijuana 162

Americans for Safe Access

JUNE 2, 2020

This new agency, the Office of Medical Cannabis Control (OMCC), would be tasked with overseeing not only the requirements of the research program, but would also enable cultivators that are already licensed in medical cannabis states to provide high quality medical cannabis to researchers, thereby increasing the diversity of products that can be used in research studies and clinical trials

DEA 163

DEA Clinical Trials History Cultivation 163

TheAnswerPage

NOVEMBER 29, 2019

Excluding potential drug:drug interactions, what adverse effects of CBD have been noted in clinical trials? In clinical trials evaluating CBD, adverse effects, including diarrhea, somnolence, decreased appetite, change in weight, and increased levels of liver enzymes have been noted. Of note, the one FDA-approved CBD product is associated with a higher risk of hepatotoxicity necessitating recommended scheduled liver function testing in patients starting the medication.

Clinical Trials 40

Clinical Trials CBD Patients 40

Leafwell

MARCH 11, 2019

How it works and what effect it has on the body is not precisely known, partially because far more clinical trials need to take place before we can say anything for sure, and partially because research on cannabinoids – even the non-psychoactive/non-intoxicating ones – is still restricted in many parts of the world. Cannabidiol (CBD) is still a big mystery in many ways.

Clinical Trials 166

Clinical Trials Chronic Pain Cannabinoids Epilepsy 166

Leafly

FEBRUARY 14, 2019

"If the clinical trial shows that hemp can help reduce blood pressure, then other treatment areas will be examined.". The post Canadian Researchers Studying Hemp Protein to Treat Hypertension appeared first on Leafly. Canada Health Science & Tech Hemp research studies

Blood Pressure 52

Blood Pressure Clinical Trials Treatment Hemp 52

NORML

JANUARY 17, 2019

A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. The act ends the University of Mississippi’s existing monopoly on the growth of cannabis for clinical research purposes, by requiring the licensing of additional manufacturers.

Legislation 176

Legislation Clinical Trials DEA Strains 176

TheAnswerPage

OCTOBER 7, 2019

Transporting [marijuana] across states lines may not be lawful under state laws, unless a patient is participating in a clinical trial and has a letter that documents such participation.” According to the Controlled Substances Act, is it legal to transport marijuana across state lines from one medical marijuana legal state to another medical marijuana legal state?

Clinical Trials 40

Clinical Trials State Laws Patients Legalization 40

TheAnswerPage

APRIL 27, 2020

Is the US VA Office of research and Development conducting any clinical trials that evaluate the use of CBD for the treatment of PTSD? The trial will compare PE + CBD to PE + placebo in a sample of 136 military Veterans with PTSD at the VA San Diego Medical Center. A RCT evaluating the efficacy of using CBD as an adjunctive to prolonged exposure therapy (PE therapy)) was started in March 2019 and will conclude on September 30,2023.

Clinical Trials 40

Clinical Trials Therapy Research and Development Treatment 40

NORML

APRIL 30, 2020

” This finding is hardly a surprise, as cannabis is well-established to mitigate pain in clinical models, particularly in patients with neuropathy. Additional clinical trial data indicates that cannabinoids possess synergistic activity with opioids, which “may allow for opioid treatment at lower doses with fewer [patient] side effects.”

Chronic Pain 195

Chronic Pain Clinical Trials Data Patients 195

Cannabis Law Report

DECEMBER 27, 2019

Virtual Clinical Trials transcend geographic, mobility and economic barriers. Clinical trials are medical research projects involving human participants. The main goals with conducting clinical studies, which could include observational studies or clinical trials, are to explore the causes of a disease or its symptoms, test a treatment, and learn how a certain behaviour affects patients’ health. Authored By : Arundati Dandapani.

Research and Development 57

Research and Development Clinical Trials Access Data 57

Cannabis Law Report

NOVEMBER 20, 2019

Since a new law took effect a year ago, England’s National Health Service (NHS) has reimbursed patients on only 18 occasions for “unlicensed” cannabis-based products that have not undergone clinical trials, according to government data. They’re also known as “specials,” meaning they did not go through clinical trials to be granted a license to be marketed.

Clinical Trials 43

Clinical Trials Data Medicine Patients 43

Leafwell

OCTOBER 17, 2018

This is how Kristin Wilcox describes the effect a cannabis-infused drug given to her daughter, Shelby Mathews, during a clinical trial on cannabinoids for Dravet Syndrome. “I saw a change almost immediately. I can’t even explain … I can’t even describe it, but it was … It was like a light started coming back into her eyes.”

Clinical Trials 100

Clinical Trials Cannabinoids Patients Epilepsy 100

TheAnswerPage

DECEMBER 6, 2019

Do the results of randomized clinical trials support those claims? According to reports in the media and statements on various CBD websites, CBD has anti-depressant effects. April 2019 systematic review on the role of cannabidiol in psychiatry found that CBD has no efficacy in depression and bipolar disorders. Preclinical studies have shown that CBD has anti-depressant effects in genetic rodent models of depression. See Answer. See Answer.

Clinical Trials 40

Clinical Trials Media CBD 40

NORML

MARCH 30, 2020

There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. By contrast, they reported that there exists “no evidence from properly designed clinical trials to support the use of CBD for the treatment” of these or other conditions, such as the flu, West Nile virus, Ebola, or common cold viruses.

Clinical Trials 176

Clinical Trials Data CBD Treatment 176

NORML

APRIL 15, 2019

Marijuana grown by the University of Mississippi for clinical research purposes is genetically divergent from strains of cannabis commercially available in retail markets, according to an analysis prepared by researchers at the University of Northern Colorado. Clinicians wishing to conduct FDA-approved clinical trials on cannabis have long complained that federally-provided samples are of inferior quality.

Clinical Trials 162

Clinical Trials Hemp Programs Strains 162

NORML

JANUARY 31, 2019

Proposed federal legislation to direct the agency to conduct clinical trials on the use of cannabis for PTSD and for other conditions is currently pending in the US House and Senate. Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA).

Clinical Trials 167

Clinical Trials Chronic Pain Data Treatment 167

CannaTech

SEPTEMBER 23, 2019

This commentary on the NICE UK cannabis guidelines is originally published by The Academy of Medical Cannabis , the globally leading institute for clinical training and research in cannabis-based medicinal products. The supportive regulatory environment has facilitated a mounting body of clinical and transnational research demonstrating the efficacy of medically prescribed marijuana.

Policy 66

Policy Research and Development Clinical Trials Patients 66